Marco Tripodi

7.3k citations
132 papers · 5.9k indexed · 1 hit paper · h-index 42

Impact in

  • Hepatology top 0.5%
    • Hepatitis C virus research
    • Liver physiology and pathology
    • MicroRNA in disease regulation
    • Cancer-related molecular mechanisms research

Papers in

    • Liver physiology and pathology 28
    • Hepatitis C virus research 16
    • Cancer-related molecular mechanisms research 11
    • MicroRNA in disease regulation 9

Marco Tripodi

128 papers receiving 5.8k citations

Hit Papers

The RNA-Binding Protein SYNCRIP Is a Component of the Hepatocyte Exosomal Machinery Controlling MicroRNA Sorting 2016 · 455 citations
4552016202620192022100200300400

Peers

Marco Tripodi
Comparison fields: 5 of 124
  • Hepatology 1.2k
  • Cancer Research 1.5k
  • Molecular Biology 3.3k
  • Epidemiology 1.1k
  • Cell Biology 488
Replace Takahiro Kodama with:
Takahiro Kodama Japan
Nathalie Wong Hong Kong
Thomas Longerich Germany
Kwan Man Hong Kong
Tomohide Tatsumi Japan
Wei Yu China
Motoko Sasaki Japan
Oliver Waidmann Germany
Bruno Sáinz Spain
Yoshiro Niitsu Japan
Marco Tripodi relative to Takahiro Kodama Japan Takahiro Kodama's profile →
Citations per field
00.5×1.7×
Takahiro Kodama · 1×
Citations per year

Countries citing papers authored by Marco Tripodi

Since Specialization
Citations

This map shows the geographic impact of Marco Tripodi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Tripodi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Tripodi more than expected).

Fields of papers citing papers by Marco Tripodi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Tripodi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Tripodi. The network helps show where Marco Tripodi may publish in the future.

Co-authors

The 25 scholars most cited alongside Marco Tripodi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Marco Tripodi Line = papers co-authored together Marco Tripodi links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20250
3 20250
4 20236
5 202210
6 202216
7 202213
8 202131
9 202048
10 202020
11 202059
12 20206
13 202054
14 201826
15 201898
16 201840
17 201615
18 200711
19 2003137
20
α1-antitripsina umana: diagnosi molecolare di mutazione e modelli animali di patologia umana
19901

About Marco Tripodi

Marco Tripodi is a scholar working on Hepatology, Cancer Research, Molecular Biology, Genetics and Oncology, having authored 132 papers that have together received 5.9k indexed citations. Recurring topics across this work include Liver physiology and pathology (28 papers), Hepatitis C virus research (16 papers), RNA Research and Splicing (14 papers), Liver Disease Diagnosis and Treatment (13 papers), Cancer-related molecular mechanisms research (11 papers), Pancreatic function and diabetes (10 papers), RNA modifications and cancer (9 papers) and MicroRNA in disease regulation (9 papers). The work is most often cited by research in Hepatology (1.2k citations), Cancer Research (1.5k citations), Molecular Biology (3.3k citations), Epidemiology (1.1k citations) and Cell Biology (488 citations). Marco Tripodi has collaborated with scholars based in Italy, United States and Spain. Frequent co-authors include Carla Cicchini, Carmine Mancone, Laura Amicone, Tonino Alonzi, Cecilia Battistelli, Laura Santangelo, Alice Conigliaro, Claudia Montaldo, Charles R. Nuttelman and Kristi S. Anseth. Their work appears in journals such as Nucleic Acids Research, Hepatology, Journal of Hepatology, Cell Death and Disease and Cell Death and Differentiation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026